Topics

Companies Related to "CrownBio NEXT Oncology Announce Strategic Model Partnership" [Most Relevant Company Matches] RSS

14:49 EST 7th December 2019 | BioPortfolio

Here are the most relevant search results for "CrownBio NEXT Oncology Announce Strategic Model Partnership" found in our extensive corporate database of over 50,000 company records.

Showing "CrownBio NEXT Oncology Announce Strategic Model Partnership" Companies 1–25 of 3,500+

Relevant

Cullinan Oncology, LLC

Cullinan Oncology is focused on investing in and developing a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model. Sourced from the Cullinan dry lab as well as external collaborators, Cullinan’s assets are managed by a single, highly experienced team of oncology professionals and drug developers across a ...


Onco360®, Oncology Pharmacy Solutions

With executive offices in New York City, Onco360 (http://onco360.com) is the largest independent provider of Oncology Pharmacy services in the country. Onco360 was founded in 2003 as OncoMed, The Oncology Pharmacy, to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals...

Oncology Hematology Care, Inc

Oncology Hematology Care, Inc,we are pleased to announce the opening of our newest clinical office in July 2006! The office is located in the medical arts building on the campus of Mercy Mt. Airy Hospital. Priya Rudolph MD and Kurt Leuenberger MD are currently seeing patients at this location. Both physicians specialize in hematology and medical oncology. In addition to physician consultation, th...


Crown Bioscience Inc.

Crown Bioscience is a global drug discovery and development service company providing translational platforms to advance oncology and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates. For more information, please visit www....

WilsonHCG

Wilson Human Capital Group, Inc., (WilsonHCG) is the premium provider and global leader in innovative talent solutions that operates on the principle of providing true partnership to our clients. Through our highly configurable Talent Ecosystem™ model, we enhance the talent function into a strategic advantage. At WilsonHCG, the relationships we develo...

Sentinel Oncology Limited

Sentinel Oncology was founded in 2005 with the vision of developing an innovative strategy for cancer treatment, ‘Targeted Synergy’ in which a single drug can be engineered to deliver two distinct activities to the unique microenvironment of a solid tumour. In 2007, Sentinel Oncology received the much sought after Wellcome Trust Seeding Drug Discovery award for the development of Tar...

Balfour Beatty Investments

Balfour Beatty Investments specializes in partnering with government entities and high performing public sector firms to implement their strategic plans through the Public-Private Partnership (PPP/P3) model. With operations in the U.S., U.K., Canada and Australia, we raise and structure finance to help customers achieve goals that might otherwise be...

Triphase Accelerator Corporation

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to advancing novel compounds through Phase 2 proof-of-concept clinical studies using a unique, science-based, high-quality model that is faster and more cost-effective than traditional p...

Formula Pharmaceuticals, Inc. and Rockland Immunochemicals, Inc.

Formula Pharmaceuticals is a privately held, immuno-oncology focused company located in Berwyn, Pennsylvania focused on the development of CAR immunotherapy for oncology and autoimmune diseases. Formula’s technology platform offers important opportunities for improvements to existing CAR approaches, with the objective to significantly increase patient...

Strategia Holdings, LLC

Strategia Holdings, LLC, is based in the U.S. and oversees three biotech companies; Spirita Oncology, LLC, Mirata BioPharma, LLC, and Strategia Pharmaceuticals, LLC. Spirita focuses on oncology drug development in the US with E6201, a MEK1 inhibitor, as their flagship candidate focused on melanoma brain metastases. Mirata is a pre-clinical stage immuno-onc...

Purple Cowboy Wines

"I am pleased to announce I am tough enough to play a pink guitar".

Dispatch Health

Dispatch Health is redefining healthcare through a unique mobile, onsite, acute-care delivery model that is high tech and low cost. Dispatch Health delivers care through multiple channels, including local municipalities and 911-first response systems, health systems, in partnership with employers and payers, and for senior care facilities. The veteran lead...

Cigna and Regional HealthPlus

Regional HealthPlus (RHP) is a network of physicians, hospitals, and other healthcare providers working in partnership with healthcare payers, including managed care companies, third-party administrators, and self-insured employers, to deliver patient focused, coordinated care. By working in partnership and focusing on putting the needs of patients first, ...

Auriga Laboratories

Auriga Laboratories™ is a specialty pharmaceutical company building an industry changing commission based-sales model. The company's high-growth business model combines driving revenues through a variable cost commission-based sales structure, acquisition of proven brand names, introduction of new brands, and a strategic development pipeline, all of which is designed to enhance its growing direc...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion for improving the lives of cancer patients. Takeda Oncology was formerly known as Millennium: The Takeda Oncology Company. Additional information about Takeda Oncology is availabl...

Hematology-Oncology Associates of CNY

Welcome to the Hematology-Oncology Associates of CNY web site. Our goal is to provide you with useful information about our practice, provide a greater understanding of our services and enrich the partnership we strive to develop with our patients.Founded in 1982, Hematology-Oncology Associates of CNY has been committed to providing the highest level of care to patients with blood disorders and c...

Pharma Growth Strategies LLC

PGS is a small firm. We believe that allows us to maximize your return on investment. Here's why.• Work with top gunsYou won't pay our people to learn your business. We have no junior partners. When you deal with the "top gun" you know you will have access to the key decision maker and action-taker. If we must subcontract, it will be with seasoned professionals.• Genuine partnershipWe need yo...

AEterna Zentaris

Committed to cure by discovering and developing innovative drugs for the treatment of patients suffering from some forms of cancer, endocrinian disorders and infectious diseases, this is our mission. Therefore, our dedicated and motivated staff is committed to the pursuit of our excellence program based on performance, quality and integrity towards patients and the healthcare community, as well a...

Concord Health Partners

Concord Health Partners (“Concord”) is a healthcare focused investment firm with a strategic partnership model that optimizes the alignment of interests between investors and portfolio companies. Concord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through products, services, techn...

OncLive

OncLive is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. The mission of OncLive and its family of publications is to provide oncology professionals with the resources and information they need to provide the best care for their...

EpiVax Oncology, Inc.

EpiVax Oncology, Inc. is a privately held biotechnology company focusing on developing precision cancer immunotherapies based in New York City, NY. Incorporated in 2017, EpiVax Oncology is a spin-out of EpiVax Inc., a company founded by Dr. Annie De Groot and Mr. Bill Martin in 1998. EpiVax Oncology is leveraging EpiVax's 20 years of experience in designing commercial-grade immunoinformatic tools...

Partnership for a Healthier America

The Partnership for a Healthier America is an independent, nonpartisan organization that will mobilize broad-based support for efforts to solve the child obesity challenge. Core activities of the Partnership include:

EcoBiotics Limited

EcoBiotics Ltd is an unlisted Australian public company, incorporated in March 2000, with a shareholder register of both private and industry investors,Our business model is designed to significantly reduce the commercial and technical risks usually associated with biotechnology investments. A key element of our model is the adoption of a semi-virtual company structure. We focus our in-house resou...

The CareGiver Partnership

The CareGiver Partnership is a national direct to consumer retailer and resource providing support, convenience, and old-fashioned customer service to those caring for a loved one, and offers more than 2,600 home care products. The CareGiver Partnership was founded in 2004 by Lynn and Tom Wilson of Neenah, Wisconsin. Visit www.caregiverpartnership.com to learn more.

Cold Spring Publishing, LLC

Cold Spring Publishing, LLC, (CSP) is a medical publishing company whose principals have more than 50 years of combined publishing experience, with a specific focus in oncology. CSP publishes JNCCN -- The Journal of the National Comprehensive Cancer Network, which covers the entire spectrum of cancer care and features updates on the NCCN Clinical Practice Guidelines in Oncology(TM). CSP also publi...


More From BioPortfolio on "CrownBio NEXT Oncology Announce Strategic Model Partnership"

Quick Search

Corporate Database Quicklinks